Ani Pharmaceuticals Stock Market Value
| ANIP Stock | USD 55.86 0.76 1.38% |
| Symbol | ANI |
ANI Pharmaceuticals Price To Book Ratio
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ANI Pharmaceuticals. If investors know ANI will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ANI Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 13.824 | Earnings Share (0.46) | Revenue Per Share 28.915 | Quarterly Revenue Growth 0.125 | Return On Assets 0.0125 |
The market value of ANI Pharmaceuticals is measured differently than its book value, which is the value of ANI that is recorded on the company's balance sheet. Investors also form their own opinion of ANI Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is ANI Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ANI Pharmaceuticals' market value can be influenced by many factors that don't directly affect ANI Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ANI Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if ANI Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ANI Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
ANI Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to ANI Pharmaceuticals' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of ANI Pharmaceuticals.
| 12/03/2022 |
| 11/22/2024 |
If you would invest 0.00 in ANI Pharmaceuticals on December 3, 2022 and sell it all today you would earn a total of 0.00 from holding ANI Pharmaceuticals or generate 0.0% return on investment in ANI Pharmaceuticals over 720 days. ANI Pharmaceuticals is related to or competes with Phibro Animal, Prestige Brand, Alkermes Plc, Dr Reddys, Collegium Pharmaceutical, Pacira BioSciences,, and Procaps Group. ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescrip... More
ANI Pharmaceuticals Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure ANI Pharmaceuticals' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess ANI Pharmaceuticals upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.1) | |||
| Maximum Drawdown | 10.82 | |||
| Value At Risk | (3.75) | |||
| Potential Upside | 3.7 |
ANI Pharmaceuticals Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for ANI Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as ANI Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use ANI Pharmaceuticals historical prices to predict the future ANI Pharmaceuticals' volatility.| Risk Adjusted Performance | (0.04) | |||
| Jensen Alpha | (0.25) | |||
| Total Risk Alpha | (0.41) | |||
| Treynor Ratio | (0.11) |
ANI Pharmaceuticals Backtested Returns
ANI Pharmaceuticals secures Sharpe Ratio (or Efficiency) of -0.0729, which signifies that the company had a -0.0729% return per unit of return volatility over the last 3 months. ANI Pharmaceuticals exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm ANI Pharmaceuticals' Risk Adjusted Performance of (0.04), coefficient of variation of (1,763), and Mean Deviation of 1.83 to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 1.25, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, ANI Pharmaceuticals will likely underperform. At this point, ANI Pharmaceuticals has a negative expected return of -0.17%. Please make sure to confirm ANI Pharmaceuticals' maximum drawdown, as well as the relationship between the accumulation distribution and price action indicator , to decide if ANI Pharmaceuticals performance from the past will be repeated in the future.
Auto-correlation | -0.07 |
Very weak reverse predictability
ANI Pharmaceuticals has very weak reverse predictability. Overlapping area represents the amount of predictability between ANI Pharmaceuticals time series from 3rd of December 2022 to 28th of November 2023 and 28th of November 2023 to 22nd of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of ANI Pharmaceuticals price movement. The serial correlation of -0.07 indicates that barely 7.0% of current ANI Pharmaceuticals price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.07 | |
| Spearman Rank Test | -0.01 | |
| Residual Average | 0.0 | |
| Price Variance | 23.83 |
ANI Pharmaceuticals lagged returns against current returns
Autocorrelation, which is ANI Pharmaceuticals stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting ANI Pharmaceuticals' stock expected returns. We can calculate the autocorrelation of ANI Pharmaceuticals returns to help us make a trade decision. For example, suppose you find that ANI Pharmaceuticals has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
ANI Pharmaceuticals regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If ANI Pharmaceuticals stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if ANI Pharmaceuticals stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in ANI Pharmaceuticals stock over time.
Current vs Lagged Prices |
| Timeline |
ANI Pharmaceuticals Lagged Returns
When evaluating ANI Pharmaceuticals' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of ANI Pharmaceuticals stock have on its future price. ANI Pharmaceuticals autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, ANI Pharmaceuticals autocorrelation shows the relationship between ANI Pharmaceuticals stock current value and its past values and can show if there is a momentum factor associated with investing in ANI Pharmaceuticals.
Regressed Prices |
| Timeline |
Pair Trading with ANI Pharmaceuticals
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if ANI Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ANI Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.Moving against ANI Stock
| 0.54 | DMAC | DiaMedica Therapeutics | PairCorr |
| 0.45 | VRDN | Viridian Therapeutics | PairCorr |
| 0.36 | SABSW | SAB Biotherapeutics | PairCorr |
The ability to find closely correlated positions to ANI Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace ANI Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back ANI Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling ANI Pharmaceuticals to buy it.
The correlation of ANI Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as ANI Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if ANI Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for ANI Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for ANI Stock Analysis
When running ANI Pharmaceuticals' price analysis, check to measure ANI Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ANI Pharmaceuticals is operating at the current time. Most of ANI Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of ANI Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ANI Pharmaceuticals' price. Additionally, you may evaluate how the addition of ANI Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.